Drug Profile
Lamivudine/nevirapine/zidovudine tablets - Hetero Drugs
Alternative Names: Lamivudine/zidovudine/nevirapine tablets - Hetero Drugs; Nevirapine/lamivudine/zidovudine tablets - Hetero Drugs; Nevirapine/zidovudine/lamivudine tablets - Hetero Drugs; Zidovudine/lamivudine/nevirapine tablets - Hetero Drugs; Zidovudine/nevirapine/lamivudine tablets - Hetero DrugsLatest Information Update: 06 Dec 2018
Price :
$50
*
At a glance
- Originator Hetero Drugs
- Class 3-ring heterocyclic compounds; Antiretrovirals; Azepines; Azides; Cyclopropanes; Deoxyribonucleosides; Dideoxynucleosides; Nucleosides; Pyridines; Pyrimidine nucleosides; Small molecules
- Mechanism of Action Non-nucleoside reverse transcriptase inhibitors; Nucleoside reverse transcriptase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Registered HIV infections
Most Recent Events
- 06 Dec 2018 Lamivudine/nevirapine/zidovudine is not yet available in USA for HIV-1 infections (PO) (Hetero Drugs website, November 2018)